Exemestane ZPHC — 25 mg × 100 tablets

Exemestane (Aromasin®) — irreversible steroidal AI
100 film-coated tablets × 25 mg

• Mechanism: permanently deactivates aromatase, lowering estrogen by ≈ 85 % and boosting endogenous testosterone.
• Research uses: post-cycle therapy, estrogen-dependent breast cancer models, mitigation of gynecomastia & water retention.
• Dose guide (research): 12.5 mg EOD for mild E2 control · 25 mg EOD during high-aromatase cycles · 25 mg daily × 2 weeks in PCT protocols.
• Lipid support: monitor HDL/LDL; consider omega-3 or niacin supplementation.
• QC: ≥ 99 % API purity (HPLC); GMP tablet press; tamper-evident cap with scratch-code authenticity.

*For laboratory research use only. Not approved as a medicinal product.*